THIETHYLPERAZIN ZUR BEHANDLUNG EINER BETA-AMYLOIDOPATHIE ODER ALPHA-SYNUCLEOPATHIE
European patent · EP2614060 · In force
Register entry
- Publication number
- EP2614060
- Application number
- EP11755294
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 30, 2011
- Published
- Jul 17, 2013
- Granted
- Aug 31, 2016
- Protection ends at the latest
- Aug 29, 2031
- Next annual fee due
- Aug 31, 2027
- IPC classes
- C07D 417/06 (2006.01)C07D 417/14 (2006.01)A61K 31/5415 (2006.01)A61P 25/28 (2006.01)G01N 33/68 (2006.01)
- Priority
- DE 102010044561 07.09.2010
- PCT application
- PCT/EP2011/064893 30.08.2011
- PCT publication
- WO2012/031941 15.03.2012
- Filing language
- German
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.08.2026 → 31.08.2027
Published in Swissreg on 01.09.2026
- Sep 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.08.2025 → 31.08.2026
Published in Swissreg on 01.09.2025
- Sep 1, 2024
Next annual fee due on
- Next annual fee due on
- 31.08.2024 → 31.08.2025
Published in Swissreg on 01.09.2024
- Sep 1, 2023
Change
Published in Swissreg on 01.09.2023
- Sep 1, 2022
Change
Published in Swissreg on 01.09.2022
- Jan 10, 2017
Agent entered
- Representative
- Schmauder & Partner AG, Patent- und Markenanwälte VSP, Zwängiweg 7, 8038 Zürich
Published in Swissreg on 10.01.2017
- Aug 31, 2016
Granted
Published in Swissreg on 31.08.2016
Parties
Agent
Inventor
PAHNKE, Jens, Prof.
39104 Magdeburg, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.